Immuneering (IMRX) Non Operating Investment Income (2021 - 2022)
Immuneering's (IMRX) quarterly Non Operating Investment Income came in at $112353.0 in Q4 2022, up 353.86% year-on-year from $24755.0 in Q4 2021, and up 187.44% quarter-over-quarter from $39088.0 in Q3 2022.
Immuneering (IMRX) Non Operating Investment Income (2021 - 2022) Analysis & Trends
Immuneering's Non Operating Investment Income history runs 2 years deep, the most recent figure standing at $112353.0 for Q4 2022.
- On a quarterly basis, Non Operating Investment Income rose 353.86% year-over-year to $112353.0 in Q4 2022; TTM through Dec 2022 was $18889.0, a N/A change from a year earlier, with the FY2022 full-year figure at $18889.0, up 138.54% from the prior year.
- Non Operating Investment Income rose to $112353.0 in Q4 2022 per IMRX's latest filing, from $39088.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $112353.0 in Q4 2022 and bottomed at -$118386.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immuneering | 279.33 Mn | 279.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 112,353.00 |
| Dec 31, 2022 | 112,353.00 |
| Sep 30, 2022 | 39,088.00 |
| Sep 30, 2022 | 39,088.00 |
| Jun 30, 2022 | -14,166.00 |
| Jun 30, 2022 | -14,166.00 |
| Mar 31, 2022 | -118,386.00 |
| Mar 31, 2022 | -118,386.00 |
| Dec 31, 2021 | -44,258.00 |
| Dec 31, 2021 | -44,258.00 |
| Sep 30, 2021 | -4,751.00 |
| Sep 30, 2021 | -4,751.00 |